Xsto Solutions, LLC, Morristown, NJ, and Kappa Bioscience AS, Oslo, Norway, have entered a new sales and marketing agreement through which Xsto will market Kappa’s line of Vitamin K2 MK-7 ingredients in the food supplement market in North America. Kappa, with its production technology, recently announced its commercialization of K2Vital, the biologically active vitamin K2 MK-7 product targeting the human nutrition market in Europe and North America.